Abstract
What have been some of the past year's key events and trends for the biopharma industry?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Concordance and predictive value of two adverse drug event data sets
BMC Medical Informatics and Decision Making Open Access 22 August 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
NEJM 356, 2457–2471 (2007).
Nature Rev. Drug Discov . 6, 505–506 (2007).
Nature Rev. Drug Discov . 6, 855–856 (2007).
Nature Rev. Drug Discov . 6, 769–771 (2007).
FDA subcommittee report [online], (2007).
Nature Rev. Drug Discov . 6, 688–689 (2007).
Nature Rev. Drug Discov . 6, 437–442 (2007).
Nature Rev. Drug Discov . 6, 590–591 (2007).
Nature Rev. Drug Discov . 6, 770–771 (2007).
Nature Rev. Drug Discov . 6, 945 (2007).
Rights and permissions
About this article
Cite this article
Hughes, B. 2007: Spotlight on drug safety. Nat Rev Drug Discov 7, 5–7 (2008). https://doi.org/10.1038/nrd2503
Issue Date:
DOI: https://doi.org/10.1038/nrd2503
This article is cited by
-
Concordance and predictive value of two adverse drug event data sets
BMC Medical Informatics and Decision Making (2014)